Skip to main content
Book cover

Hyperglycemia, Diabetes and Vascular Disease

  • Book
  • © 1992

Overview

  • There are over 12 million people with diabetes in the US
  • The authors review clinical, epidemiological, and biochemical evidence that high levels of blood glucose produce metabolic and biochemical alterations in vascular walls
  • Based on a 1989 FASEB symposium by the APS

Part of the book series: Clinical Physiology (CLINPHY)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (15 chapters)

  1. Epidemiology and Physiology

  2. Polyols, myo-Inositol, and Signal Transduction

  3. Glycation Products and Glycosoaminoglycans

Keywords

About this book

It is estimated that 1-5% ofthe world's population is affected by some form of diabetes. Patients with these disorders are highly likely to develop microvas­ cular pathology in the retina and glomerulus and they are at a 2--6-fold greater risk for atherosclerotic vascular disease than individuals without diabetes. In addition, hypertension is far more prevalent in patients with diabetes than in the general population. As a consequence of these complications, diabetes is a leading cause of blindness and renal failure in young and middle-aged adults and it is a major risk factor for coronary heart disease, stroke and peripheral vascular disease in the Western world. An understanding of the relationship of these vascular complications to diabetic hyperglycemia has become a critical issue for clinicians in recent years, since the prevalence of diabetes appears to be increasing dramatically world-wide. In addition, it is now possible to achieve improved glycemic control in many patients-although not without incurring other risks. This volume explores two principal hypotheses concerning these complications. One is that hyperglycemia underlies or at least contributes to the pathogenesis of both micro- and macrovascular disease in patients with diabetes. The other is that it does so by producing specific metabolic and biochemical alterations in the vascular wall that lead to abnormalities in its function and ultimately its structure.

Editors and Affiliations

  • Diabetes and Metabolism Unit, Evans Memorial Department of Clinical Research and Department of Physiology, Boston University School of Medicine, Boston, USA

    Neil Ruderman

  • Department of Pathology, Washington University School of Medicine, St. Louis, USA

    Joseph Williamson

  • Diabetes Research Center and Departments of Medicine and Pathology, Albert Einstein College of Medicine, Bronx, USA

    Michael Brownlee

Bibliographic Information

  • Book Title: Hyperglycemia, Diabetes and Vascular Disease

  • Editors: Neil Ruderman, Joseph Williamson, Michael Brownlee

  • Series Title: Clinical Physiology

  • DOI: https://doi.org/10.1007/978-1-4614-7524-8

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: American Physiological Society 1992

  • eBook ISBN: 978-1-4614-7524-8Published: 27 May 2013

  • Edition Number: 1

  • Number of Pages: 320

  • Additional Information: Originally Published by Oxford University Press 1992

  • Topics: Human Physiology

Publish with us